This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Sarolta Benko Nee Markus
Introduction
Sarolta Benko Nee Markus is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for valuable compounds. Her work has implications for medical advancements, especially in the area of blood platelet aggregation.
Latest Patents
Sarolta holds a patent for a process related to the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]-quinazolin-2[3H]-one, commonly known as anagrelide. This compound is recognized for its effectiveness as a blood platelet antiaggregative agent. The patented process involves the thermal cyclization of a new 2-cyanoiminoquinazoline derivative in an acidic medium, which allows for the industrial-scale production of anagrelide. This innovative method addresses the limitations of previous processes, making it a significant advancement in pharmaceutical manufacturing.
Career Highlights
Sarolta is currently associated with Egis Gyógyszergyár, a prominent pharmaceutical company in Hungary. Her role at the company has allowed her to focus on research and development, contributing to the advancement of medical science through her innovative processes.
Collaborations
Throughout her career, Sarolta has collaborated with esteemed colleagues, including Margit Csorgo and Dezso Danyi. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical processes.
Conclusion
Sarolta Benko Nee Markus exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the preparation of anagrelide, highlight the importance of research and development in creating effective medical solutions. Her work continues to impact the field positively, paving the way for future advancements.